Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1400873 | 0.71 | CA2 (0.54) | CA2CA4CA5AFDPSCES2 | |
| SCHEMBL29822627 | 0.71 | CA2 (0.54) | CA2CA4CA5AFDPSCES2 | |
| Phosphoric Acid SCHEMBL28095761 | 0.71 | FDPS (0.41) | FDPSP2RX7LMNA | |
| Phosphoric Acid SCHEMBL28192934 | 0.71 | HSP90AA1 (0.67) | FDPSP2RX7HDAC8NAPRTHSP90AA1 | |
| SCHEMBL2595451 | 0.69 | TDP1 (0.43) | CA2CA4CA5AFDPSCES1 | |
| Phosphoric Acid SCHEMBL28528859 | 0.69 | ALDH1A1 (0.50) | FDPSKDM4E | |
| SCHEMBL28361684 | 0.69 | MMP1 (0.41) | CA2CA4CA5AFDPS | |
| Phosphoric Acid SCHEMBL459067 | 0.67 | FDPS (0.38) | FDPSP2RX7L3MBTL1 | |
| Phosphoric Acid SCHEMBL938025 | 0.67 | FDPS (0.38) | FDPSP2RX7L3MBTL1 | |
| Dipyridyl SCHEMBL10772309 | 0.67 | KDM4E (0.70) | FDPSHDAC8LMNAP4HTML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100099869-A1 | NOVEL NUCLEOTIDE ANALOGUES AS PRECUSOR MOLECULES FOR ANTIVIRALS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2010-04-22 | — | — | US | claimed |
| EP-2086990-A2 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | Centre National De La Recherche Scientifique-CNRS (FR) | 2009-08-12 | — | — | EP | claimed |
| WO-2008056264-A2 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2008-05-15 | — | — | WO | claimed |
| CN-101041669-A | Non nucleoside reverse transcriptase inhibitors | GILEAD SCIENCES INC (US) | 2007-09-26 | — | — | CN | claimed |
| CN-1656109-A | Non-nucleoside reverse transcriptase inhibitors | GILEAD SCIENCES INC (US) | 2005-08-17 | — | — | CN | claimed |
| US-5277788-A | Twice-anodized aluminum article having an organo-phosphorus monolayer and process for making the article | ALUMINUM COMPANY OF AMERICA (US) | 1994-01-11 | — | — | US | claimed |
| EP-3416205-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10711091-B2 | Light-emitting device and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
| EP-3416205-A1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | Sumitomo Chemical Company, Ltd (JP) | 2018-12-19 | — | — | EP | disclosed |
| US-8884011-B2 | Nucleotide analogues as precursor molecules for antivirals | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2014-11-11 | — | — | US | disclosed |
| US-8884011-B2 | Nucleotide analogues as precursor molecules for antivirals | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2014-11-11 | — | — | US | disclosed |
| CN-101759720-B | Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same | SHANGHAI SINCH PHARMACEUTICALS TECHNOLOGY CO LTD | 2013-01-23 | — | — | CN | disclosed |
| EP-2086990-A2 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | Centre National De La Recherche Scientifique-CNRS (FR) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008056264-A3 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | CT NAT DE RECH SCIENT CNRS (FR) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008056264-A2 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008056264-A2 | NOVEL NUCLEOTIDE ANALOGUES AS PERCURSOR MOLECULES FOR ANTIVIRALS | CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2008-05-15 | — | — | WO | disclosed |
| CN-101041669-A | Non nucleoside reverse transcriptase inhibitors | GILEAD SCIENCES INC (US) | 2007-09-26 | — | — | CN | disclosed |
| CN-1656109-A | Non-nucleoside reverse transcriptase inhibitors | GILEAD SCIENCES INC (US) | 2005-08-17 | — | — | CN | disclosed |
| US-5277788-A | Twice-anodized aluminum article having an organo-phosphorus monolayer and process for making the article | ALUMINUM COMPANY OF AMERICA (US) | 1994-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711091-B2 | Light-emitting device and method for producing same | SCO2, SUN2, SLC18A2 | CA2 3004/4885CA4 2197/4885CA5A 2646/4885 |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | SCO2, SUN2, SLC18A2 | CA2 3004/4885CA4 2197/4885CA5A 2646/4885 |
| US-20100099869-A1 | NOVEL NUCLEOTIDE ANALOGUES AS PRECUSOR MOLECULES FOR ANTIVIRALS | NUDT1, P2RY1, HPRT1 | CA2 2546/4885CA4 2048/4885CA5A 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.